JP Morgan Chase
KMTS

JP Morgan Chase’s Kestra Medical Technologies KMTS Stock Holding History

JP Morgan Chase’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$506K Sell
18,657
-7,129
-28% -$149K ﹤0.01% 5117
2026
Q1 		$473K Buy
25,786
+5,997
+30% +$141K ﹤0.01% 5075
2025
Q4 		$525K Buy
19,789
+5,364
+37% +$138K ﹤0.01% 4987
2025
Q3 		$343K Sell
14,425
-1,044
-7% -$18.7K ﹤0.01% 5239
2025
Q2 		$256K Buy
+15,469
New +$338K ﹤0.01% 5117

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase's KMTS Position: Q2 2026 in Review

JP Morgan Chase reduced its Kestra Medical Technologies (KMTS) stake by 28% in Q2 2026, selling an estimated $149K and leaving 18,657 shares worth $506K. The position accounts for ﹤0.01% of the portfolio, ranked #5117.

JP Morgan Chase first reported a position in KMTS in Q2 2025 and has held it in 5 quarters since. The position peaked at $525K in Q4 2025. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • JP Morgan Chase held 18,657 shares of Kestra Medical Technologies worth $506K as of Q2 2026.
  • JP Morgan Chase sold 7,129 Kestra Medical Technologies shares in Q2 2026, an estimated $149K.
  • Kestra Medical Technologies made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5117 holding.
  • JP Morgan Chase first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 5 quarters since.
  • JP Morgan Chase's Kestra Medical Technologies position peaked at $525K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.